Houlihan Lokey Advises ArtesRx

Houlihan Lokey is pleased to announce that ArtesRx, a portfolio company of Flexpoint Ford (Flexpoint), has been acquired by Linden Capital Partners (Linden). The transaction closed on August 20, 2026. Houlihan Lokey served as the exclusive financial advisor to ArtesRx.

ArtesRx is a behavioral health pharmacy platform serving individuals who depend on complex medication regimens, including patients with serious mental illness, substance use disorders, and intellectual and developmental disabilities. The company operates 16 pharmacies under local banners with long-standing community and provider relationships.

Flexpoint is a specialist private equity firm focused on financial services and adjacent verticals. Founded in 2005, the firm manages approximately $9 billion in assets and operates as a single, integrated platform investing through two complementary strategies: Private Equity and Asset Opportunities. Over two decades, Flexpoint has completed more than 100 investments, leveraging deep sector expertise and structural flexibility to drive long-term value across a wide range of investment structures and market cycles. Flexpoint is headquartered in Chicago with offices in New York and Miami.

Linden is a Chicago-based private equity firm focused exclusively on the healthcare industry. Founded in 2004, Linden is the largest dedicated healthcare private equity firm. Linden’s strategy is based upon three elements: (i) healthcare specialization, (ii) integrated private equity and operating expertise, and (iii) its differentiated human capital program. Since its founding, Linden has invested in more than 50 healthcare companies encompassing over 400 total transactions across its strategies. The firm currently manages $14 billion of regulatory assets under management.

This transaction further highlights Houlihan Lokey’s leadership in the pharmacy sector, becoming its 13th closed transaction in under two years. It is also the firm’s third behavioral health pharmacy transaction in the past nine months. Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the world. In 2025, the group closed 35 transactions in the U.S. and was ranked by LSEG as the No. 1 advisor for all global healthcare M&A transactions.*

Houlihan Lokey served as the exclusive financial advisor to ArtesRx and assisted in initiating, structuring, and negotiating the transaction on its behalf.

*Source: LSEG. Excludes accounting firms and brokers.

RELATED: Healthcare, Mergers and Acquisitions